ARTICLE | Clinical News
Alteon preclinical data
September 25, 2006 7:00 AM UTC
In a mouse model of diabetic nephropathy, alagebrium protected against advanced glycosylation end-product (A.G.E.) mediated effects on the kidney. Alagebrium, a A.G.E crosslink breaker reduced serum,...